.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BH07_Evogliptin.Evogliptin

Information

name:Evogliptin
ATC code:A10BH07
route:oral
n-compartments2

Evogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. It works by increasing incretin levels, which inhibit glucagon release, increase insulin secretion, and decrease gastric emptying. Evogliptin is approved for use in some countries, including South Korea and Brazil.

Pharmacokinetics

Pharmacokinetic parameters were reported in healthy adult volunteers after single and multiple oral doses.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos